RxCelerate Assembles a World-Class Scientific Advisory Board for its Biologics Discovery Unit

05/05/2025

Campus-based @RxCelerate has revealed a world-class Scientific Advisory Board for its rapidly growing antibody discovery group, RxBiologics, chaired by RxBiologics co-founder and world-renowned antibody engineer Jonny Finlay.

RxCelerate, the Cambridge-based out-sourced drug discovery and development leader, has unveiled a world-class Scientific Advisory Board (SAB) for its rapidly growing antibody discovery group, RxBiologics.

The SAB will be chaired by RxBiologics co-founder and world-renowned antibody engineer Jonny Finlay.  Jonny was responsible for the initial design of the Galaxy® display library platform that RxBiologics launched in February 2021, which incorporates the world’s first in-line optimisation technology that mimics the way B cells generate high affinity and specificity antibodies in vivo.  As a result, Galaxy® has repeatedly delivered clinic-ready antibody clones straight from the library.